These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 3914417)

  • 1. [Secretion of pancreatic polypeptide and glucagon in patients with diabetes mellitus after the administration of insulin].
    Kuska J; Kokot F; Błasiak M
    Endokrynol Pol; 1985; 36(6):323-31. PubMed ID: 3914417
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of influence of residual beta-cell function on the glucagon and pancreatic polypeptide secretion in type I (insulin-dependent) diabetic patients.
    Tronier B; Madsbad S; Krarup T; Faber OK
    Diabete Metab; 1987 Apr; 13(2):141-3. PubMed ID: 3297833
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of negative feed-back regulation of insulin on the responses of gastric inhibitory polypeptide, insulin, glucagon and pancreatic polypeptide to a meal in insulin treated diabetics.
    Krarup T; Madsbad S; Tronier B
    Diabete Metab; 1984 Sep; 10(3):171-4. PubMed ID: 6386555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Kennedy FP; Bolli GB; Go VL; Cryer PE; Gerich JE
    J Clin Endocrinol Metab; 1987 Mar; 64(3):602-8. PubMed ID: 3818892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine.
    Weir GC; Samols E; Loo S; Patel YC; Gabbay KH
    Diabetes; 1979 Jan; 28(1):35-40. PubMed ID: 759249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The incretory function of the pancreas in patients with pulmonary tuberculosis and diabetes mellitus].
    Egorova IL
    Probl Tuberk; 1991; (9):36-8. PubMed ID: 1749754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes.
    Tsuchiyama N; Takamura T; Ando H; Sakurai M; Shimizu A; Kato K; Kurita S; Kaneko S
    Diabetes Care; 2007 Oct; 30(10):2583-7. PubMed ID: 17644622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secretion of gastrin, pancreatic polypeptide and glucagon in persons with simple obesity].
    Szurkowski M; Daniel K; Kokot F; Grzeszczak W
    Pol Tyg Lek; 1987 May; 42(20):613-7. PubMed ID: 3671156
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ratio of somatostatin-glucagon secretion in diabetes mellitus].
    Kostiuk EP
    Fiziol Zh (1978); 1985; 31(2):195-201. PubMed ID: 2860024
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.
    Diem P; Redmon JB; Abid M; Moran A; Sutherland DE; Halter JB; Robertson RP
    J Clin Invest; 1990 Dec; 86(6):2008-13. PubMed ID: 2254456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic volume and endocrine and exocrine functions in patients with diabetes.
    Philippe MF; Benabadji S; Barbot-Trystram L; Vadrot D; Boitard C; Larger E
    Pancreas; 2011 Apr; 40(3):359-63. PubMed ID: 21283038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Release of pancreatic polypeptide after administration of cholecystokinin in children with mucoviscidosis].
    Cichy W; Socha J; Barra E
    Pediatr Pol; 1985 Jun; 60(6):440-4. PubMed ID: 4069838
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
    Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
    J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion.
    Yabe D; Kuroe A; Ohya M; Watanabe K; Kitatani N; Oku M; Kurose T; Seino Y
    Diabetes Res Clin Pract; 2008 Nov; 82(2):e1-4. PubMed ID: 18789550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exocrine pancreatic function among diabetic patients in Thailand.
    Hitanant S; Vannasaeng S; Tan-ngarm-trong D; Plengvanit U; Viranuvatti V
    Am J Gastroenterol; 1986 Jul; 81(7):559-61. PubMed ID: 2424300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of arginine vasopressin in diabetes-associated increase in glucagon secretion.
    Yibchok-anun S; Abu-Basha EA; Yao CY; Panichkriangkrai W; Hsu WH
    Regul Pept; 2004 Nov; 122(3):157-62. PubMed ID: 15491785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic polypeptide-secreting islet-cell tumors. A study of three cases.
    Tomita T; Friesen SR; Kimmel JR; Doull V; Pollock HG
    Am J Pathol; 1983 Nov; 113(2):134-42. PubMed ID: 6314815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.
    Baron AD; Kim D; Weyer C
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impaired insulin secretion in diabetes mellitus].
    Aoki S
    Rinsho Byori; 1984 Mar; 32(3):260-5. PubMed ID: 6376873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.